Amgen (AMGN) Other Non-Current Assets (2009 - 2026)
Amgen (AMGN) recorded Other Non-Current Assets of $12.98 billion in Q2 2026, up 17.7% from $11.02 billion a year earlier and up 1.7% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) Other Non-Current Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Amgen reported Other Non-Current Assets of $12.66 billion, up 27.5% from FY2024.
- Annual Other Non-Current Assets has increased for three straight years, with a five-year compound annual growth rate of 17.6% (FY2020 to FY2025).
- Across earlier years, Other Non-Current Assets came in at $9.93 billion in FY2024 (+3.3%), $9.61 billion in FY2023 (+62.9%), $5.9 billion in FY2022 (-9.6%) and $6.52 billion in FY2021 (+15.7%).
- Quarterly Other Non-Current Assets has ranged from $5.9 billion in Q4 2022 to $13.22 billion in Q3 2025 over the past five years.
- On a year-over-year basis, Other Non-Current Assets has increased for 14 consecutive quarters, with growth averaging 21.5% over the last eight quarters.
- Peak year-over-year performance for Other Non-Current Assets in the last five years was growth of 62.9% in Q4 2023, against a decline of 9.6% in Q4 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $12.76 billion (Q1 2026), $12.66 billion (Q4 2025) and $13.22 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 7.48 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 15.10 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 10.73 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 19.60 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 5.93 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | - |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 12.98 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 4.75 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 9.94 Bn |
| 10 | Vertex Pharmaceuticals | 135.58 Bn | 107.59 Bn | 2.84 Bn | 1.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.98 Bn |
| Mar 31, 2026 | 12.76 Bn |
| Dec 31, 2025 | 12.66 Bn |
| Sep 30, 2025 | 13.22 Bn |
| Jun 30, 2025 | 11.02 Bn |
| Mar 31, 2025 | 11.39 Bn |
| Dec 31, 2024 | 9.93 Bn |
| Sep 30, 2024 | 10.38 Bn |
| Jun 30, 2024 | 8.82 Bn |
| Mar 31, 2024 | 9.01 Bn |
| Dec 31, 2023 | 9.61 Bn |
| Sep 30, 2023 | 7.84 Bn |
| Jun 30, 2023 | 7.19 Bn |
| Mar 31, 2023 | 7.63 Bn |
| Dec 31, 2022 | 5.90 Bn |
| Sep 30, 2022 | 6.34 Bn |
| Jun 30, 2022 | 6.02 Bn |
| Mar 31, 2022 | 6.07 Bn |
| Dec 31, 2021 | 6.52 Bn |
| Sep 30, 2021 | 6.31 Bn |
API Access
Amgen Other Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-non-current-assets", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();